• Skip to navigation
  • Skip to main content

Polyneuron Pharmaceuticals

  • Home
  • Technology
  • Pipeline
  • Company
  • Careers
  • Contact
  • News
  • Facebook
  • Twitter

April 7, 2020 General
Polyneuron announces appointment of chief medical officer

We are extremely pleased to welcome Dr Debra Barker to Polyneuron as our new chief medical officer.

Dr Barker has a successful track record in drug development spanning over 25 years, involving many successful drug approvals. Press Release


In other news

  • October 7, 2020 Uncategorized
    Polyneuron appoints Aled Williams as chief business officer

    We are extremely pleased to welcome Aled Williams to Polyneuron… [read on]

  • September 16, 2020 General
    Polyneuron extends Series A to CHF 36.5 million

    Polyneuron announces a CHF 14 million extension of the Series… [read on]

  • June 5, 2020 General
    Polyneuron's PN-1007 Receives U.S. FDA Orphan Drug Designation in Anti-MAG Neuropathy

    Polyneuron is proud to announce that the U.S. Food and… [read on]

  • April 27, 2020 General
    Polyneuron receives approval to begin clinical study with PN-1007 in anti-MAG neuropathy

    We are very proud to have received our… [read on]

  • September 5, 2019 General
    Polyneuron annouces appointment of new Chairman

    Polyneuron announces the appointment of Ben Machielse as Chairman of… [read on]

  • March 28, 2019 Financing
    Polyneuron raises CHF 22.5 million in a major Series A financing

    Polyneuron raises CHF 22.5 million in an oversubscribed… [read on]

  • May 15, 2018 Financing
    Completion of financing and team strengthening

    Polyneuron announces the completion of a… [read on]

  • January 31, 2018 Awards
    Polyneuron supported by BaseLaunch Accelerator

    After a first grant of CHF 10’000 during Phase… [read on]

Polyneuron |info@polyneuron.com

Imprint | Privacy policy